Search Ontology:
ChEBI

tofacitinib

Term ID
CHEBI:71200
Synonyms
  • 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile
  • CP 690550
  • CP-690550
  • Tasocitinib
  • tofacitinib
  • tofacitinibum
Definition
A pyrrolopyrimidine that is pyrrolo[2,3-d]pyrimidine substituted at position 4 by an N-methyl,N-(1-cyanoacetyl-4-methylpiperidin-3-yl)amino moiety. Used as its citrate salt to treat moderately to severely active rheumatoid arthritis.
References
  • cas:477600-75-2
  • drugcentral:4713
  • kegg.drug:D09970
  • lincs.smallmolecule:LSM-1227
  • patent:WO2007012953
  • patent:WO2007107318
  • patent:WO2010123919
  • pdb-ccd:MI1
  • pubmed:21952978
  • pubmed:21971513
  • pubmed:22006202
  • pubmed:22147632
  • pubmed:22233204
  • pubmed:22357358
  • pubmed:22460142
  • pubmed:22474037
  • pubmed:22525048
  • pubmed:22576568
  • pubmed:22591402
  • pubmed:22607178
  • pubmed:22607938
  • pubmed:22682022
  • pubmed:22802024
  • pubmed:22873530
  • pubmed:22873531
  • pubmed:22894574
  • pubmed:22899318
  • pubmed:22916341
  • pubmed:22924949
  • pubmed:22960764
  • pubmed:23055694
  • pubmed:23150969
  • pubmed:23150970
  • pubmed:23150971
  • reaxys:11647225
  • wikipedia.en:Tofacitinib
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from tofacitinib
Phenotype where environments contain tofacitinib
Phenotype modified by environments containing tofacitinib
Phenotype affecting tofacitinib
Human Disease Model